|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.200 USD | +3.77% |
|
-3.08% | +91.30% |
| 06-30 | Lexicon Pharmaceuticals, Inc.(NasdaqCM:LXRX) added to Russell Small Cap Comp Growth Benchmark | CI |
| 06-29 | Lexicon Pharmaceuticals, Inc.(NasdaqCM:LXRX) added to Russell 2000 Index | CI |
| Market Cap | 977M 854M 788M 725M 1.37B 94.03B 1.4B 9.41B 3.69B 45.96B 3.67B 3.59B 158B | P/E 2026 * |
-14x | P/E 2027 * | -11.6x |
|---|---|---|---|---|---|
| Enterprise Value | 977M 854M 788M 725M 1.37B 94.03B 1.4B 9.41B 3.69B 45.96B 3.67B 3.59B 158B | EV / Sales 2026 * |
25.6x | EV / Sales 2027 * | 48.5x |
| Free-Float |
98.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexicon Pharmaceuticals, Inc.
| 1 day | +3.77% | ||
| 1 week | -3.08% | ||
| Current month | -8.33% | ||
| 1 month | +12.24% | ||
| 3 months | +18.28% | ||
| 6 months | +71.88% | ||
| Current year | +91.30% |
| 1 week | 2.04 |  | 2.25 |
| 1 month | 1.95 | | 2.68 |
| Current year | 1.1 | | 2.68 |
| 1 year | 1 | | 2.68 |
| 3 years | 0.28 | | 3.73 |
| 5 years | 0.28 | | 6.33 |
| 10 years | 0.28 | | 19.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Exton
CEO | Chief Executive Officer | 56 | 08/07/2024 |
Scott Coiante
DFI | Director of Finance/CFO | 59 | 02/01/2025 |
Michael Davies
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Barker
CHM | Chairman | 83 | 01/01/2005 |
Ray Debbane
CHM | Chairman | 71 | 27/02/2012 |
| Director/Board Member | 67 | 28/08/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-03 | Fiscal year | Director | 178,624 | 0.0402% | ||
| 06-03 | Fiscal year | Director | 178,624 | 0.0402% | ||
| 06-03 | The Invus Group LLC
| Other | Company | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.77% | -3.08% | +91.30% | -0.45% | 977M | |
| +3.13% | +13.95% | +64.21% | +94.35% | 57.82B | |
| -0.53% | -6.30% | +53.62% | +70.61% | 53.71B | |
| -0.27% | -5.77% | +6.75% | +433.06% | 23.8B | |
| +1.76% | -1.65% | -16.86% | -15.01% | 23.26B | |
| -0.56% | +6.10% | +44.56% | -3.75% | 20.7B | |
| -1.19% | -2.98% | +33.13% | -30.29% | 17.81B | |
| +10.00% | -4.30% | +208.33% | +370.99% | 16.9B | |
| -2.61% | +10.00% | +47.02% | +699.54% | 16.36B | |
| -0.39% | -1.00% | +26.08% | +186.49% | 13.96B | |
| Average | +1.31% | +0.97% | +55.81% | +180.55% | 24.53B | |
| Weighted average by Cap. | +1.14% | +1.33% | +51.43% | +158.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.17M 33.37M 30.78M 28.3M 53.62M 3.67B 54.53M 367M 144M 1.79B 143M 140M 6.19B | 20.15M 17.62M 16.25M 14.94M 28.31M 1.94B 28.79M 194M 76.14M 948M 75.68M 74.02M 3.27B |
| Net income | -66.94M -58.52M -53.99M -49.63M -94.03M -6.44B -95.64M -645M -253M -3.15B -251M -246M -10.85B | -88.26M -77.17M -71.18M -65.44M -124M -8.49B -126M -850M -333M -4.15B -331M -324M -14.31B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | $2.200 | +3.77% | 4,408,666 |
| 14/07/26 | $2.120 | -2.30% | 1,541,127 |
| 13/07/26 | $2.170 | -2.25% | 1,705,614 |
| 10/07/26 | $2.220 | -1.33% | 2,299,214 |
| 09/07/26 | $2.250 | -0.88% | 1,465,319 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXRX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
